KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Gross Profit (2016 - 2025)

Idexx Laboratories has reported Gross Profit over the past 17 years, most recently at $658.1 million for Q4 2025.

  • Quarterly results put Gross Profit at $658.1 million for Q4 2025, up 15.33% from a year ago — trailing twelve months through Dec 2025 was $2.7 billion (up 11.8% YoY), and the annual figure for FY2025 was $2.7 billion, up 11.8%.
  • Gross Profit for Q4 2025 was $658.1 million at Idexx Laboratories, down from $683.4 million in the prior quarter.
  • Over the last five years, Gross Profit for IDXX hit a ceiling of $694.7 million in Q2 2025 and a floor of $456.4 million in Q4 2021.
  • Median Gross Profit over the past 5 years was $545.5 million (2023), compared with a mean of $556.1 million.
  • Biggest five-year swings in Gross Profit: soared 30.92% in 2021 and later grew 5.05% in 2022.
  • Idexx Laboratories' Gross Profit stood at $456.4 million in 2021, then grew by 6.25% to $484.9 million in 2022, then increased by 8.5% to $526.2 million in 2023, then grew by 8.46% to $570.7 million in 2024, then rose by 15.33% to $658.1 million in 2025.
  • The last three reported values for Gross Profit were $658.1 million (Q4 2025), $683.4 million (Q3 2025), and $694.7 million (Q2 2025) per Business Quant data.